ARHGAP29
Rho GTPase-activating protein 29
Also known as: PARG1, RHG29_HUMAN
Cross-references: UniProt · Ensembl · Human Protein Atlas · GeneCards · NCBI Gene
Protein identityUniProt · HPA
- UniProt accession
- Q52LW3
- Gene
- ARHGAP29
- Ensembl
- ENSG00000137962
- Chromosome
- 1
- Canonical length
- 1261 aa
- Protein class
- Predicted intracellular proteins
- Subcellular location
- Nucleoplasm,Plasma membrane,Centrosome,Cytosol
OverviewNCBI Gene
Rap1 is a small GTPase that, through effectors, regulates Rho GTPase signaling. These effectors- Rasip1, Radil, and the protein encoded by this gene- translocate to the cell membrane, where they form a multiprotein complex. This complex is necessary for Rap1-induced inhibition of Rho signaling. Defects in this gene may be a cause of nonsyndromic cleft lip with or without cleft palate. [provided by RefSeq, Jun 2016]
Canonical amino-acid sequenceUniProt
1261 residues, UniProt reviewed canonical sequence.
>Q52LW3|ARHGAP29
1 MIAHKQKKTK KKRAWASGQL STDITTSEMG LKSLSSNSIF DPDYIKELVN DIRKFSHMLL
61 YLKEAIFSDC FKEVIHIRLE ELLRVLKSIM NKHQNLNSVD LQNAAEMLTA KVKAVNFTEV
121 NEENKNDLFQ EVFSSIETLA FTFGNILTNF LMGDVGNDSL LRLPVSRETK SFENVSVESV
181 DSSSEKGNFS PLELDNVLLK NTDSIELALS YAKTWSKYTK NIVSWVEKKL NLELESTRNM
241 VKLAEATRTN IGIQEFMPLQ SLFTNALLND IESSHLLQQT IAALQANKFV QPLLGRKNEM
301 EKQRKEIKEL WKQEQNKMLE AENALKKAKL LCMQRQDEYE KAKSSMFRAE EEHLSSSGGL
361 AKNLNKQLEK KRRLEEEALQ KVEEANELYK VCVTNVEERR NDLENTKREI LAQLRTLVFQ
421 CDLTLKAVTV NLFHMQHLQA ASLADSLQSL CDSAKLYDPG QEYSEFVKAT NSTEEEKVDG
481 NVNKHLNSSQ PSGFGPANSL EDVVRLPDSS NKIEEDRCSN SADITGPSFI RSWTFGMFSD
541 SESTGGSSES RSLDSESISP GDFHRKLPRT PSSGTMSSAD DLDEREPPSP SETGPNSLGT
601 FKKTLMSKAA LTHKFRKLRS PTKCRDCEGI VVFQGVECEE CLLVCHRKCL ENLVIICGHQ
661 KLPGKIHLFG AEFTQVAKKE PDGIPFILKI CASEIENRAL CLQGIYRVCG NKIKTEKLCQ
721 ALENGMHLVD ISEFSSHDIC DVLKLYLRQL PEPFILFRLY KEFIDLAKEI QHVNEEQETK
781 KNSLEDKKWP NMCIEINRIL LKSKDLLRQL PASNFNSLHF LIVHLKRVVD HAEENKMNSK
841 NLGVIFGPSL IRPRPTTAPI TISSLAEYSN QARLVEFLIT YSQKIFDGSL QPQDVMCSIG
901 VVDQGCFPKP LLSPEERDIE RSMKSLFFSS KEDIHTSESE SKIFERATSF EESERKQNAL
961 GKCDACLSDK AQLLLDQEAE SASQKIEDGK TPKPLSLKSD RSTNNVERHT PRTKIRPVSL
1021 PVDRLLLASP PNERNGRNMG NVNLDKFCKN PAFEGVNRKD AATTVCSKFN GFDQQTLQKI
1081 QDKQYEQNSL TAKTTMIMPS ALQEKGVTTS LQISGDHSIN ATQPSKPYAE PVRSVREASE
1141 RRSSDSYPLA PVRAPRTLQP QHWTTFYKPH APIISIRGNE EKPASPSAAV PPGTDHDPHG
1201 LVVKSMPDPD KASACPGQAT GQPKEDSEEL GLPDVNPMCQ RPRLKRMQQF EDLEGEIPQF
1261 VLocalizationUniProt · AlphaFold · HPA
Whether an antibody against ARHGAP29 can act on the native protein depends on physical access: surface and secreted proteins are reachable by circulating antibodies, intracellular proteins usually are not.
- Antibody reachability
- Intracellular
- Secreted
- No
- Transmembrane segments
- 0
- Mean surface accessibility (rSASA)
- 0.49
- Highest tissue expression
- 22 nTPM
Expression across tissuesHPA
Tissue
- adipose tissue: 22 nTPM
- breast: 21 nTPM
- spleen: 21 nTPM
- lung: 19 nTPM
- placenta: 16 nTPM
- liver: 16 nTPM
Single-cell type
- lymphatic endothelial cells: 590 nCPM
- vascular endothelial cells: 544 nCPM
- loop of henle epithelial cells: 488 nCPM
- renal connecting tubule cells: 415 nCPM
- podocytes: 401 nCPM
- breast secretory cells: 308 nCPM
Immune cell
- non-classical monocyte: 1.1 nTPM
- intermediate monocyte: 0.8 nTPM
- classical monocyte: 0.4 nTPM
- basophil: 0 nTPM
- eosinophil: 0 nTPM
- gdT-cell: 0 nTPM
Brain region
- cerebellum: 45 nTPM
- thalamus: 17 nTPM
- choroid plexus: 14 nTPM
- pons: 14 nTPM
- amygdala: 13 nTPM
- medulla oblongata: 13 nTPM
DiseaseUniProt · ClinVar · IEDB · PubMed
Four sources answering four different questions about ARHGAP29.
Disease | GeneticClinVar
7 pathogenic / likely-pathogenic of 227 ClinVar records.
Conditions with pathogenic or likely-pathogenic variants.
- Nonsyndromic cleft lip with or without cleft palate
- ARHGAP29-related disorder
Genetic constraint and essentialitygnomAD · DepMap
Does the body need this protein intact? Low LOEUF or a strong DepMap dependency means loss or blockade of the protein is likely to be felt.
- gnomAD LOEUF (loss-of-function intolerance)
- 0.25
- gnomAD pLI
- 1
- gnomAD missense Z
- 1.21
- DepMap mean gene effect
- -0.28
- DepMap dependency class
- selective
Cancer expressionTCGA
Across TCGA tumor cohorts, this protein is over-expressed in roughly 4% of surveyed tumor types (aggregate summary; per-cohort expression, alteration, and survival load in the interactive view).
OntologyGO
Biological processes
- negative regulation of small GTPase mediated signal transduction
- regulation of small GTPase mediated signal transduction
- Rho protein signal transduction
Molecular functions
Cellular components
Protein domainsUniProt · Pfam · InterPro
- Rho GTPase-activating protein domain
- Protein kinase C-like, phorbol ester/diacylglycerol-binding domain
- Rho GTPase activation protein
- AH/BAR domain superfamily
- F-BAR domain
- C1-like domain superfamily
- Rho GTPase-activating
- GMIP/FCHO2-like, FCH domain
- Rho GTPase-activating protein 29/45, N-terminal
- Phorbol esters/diacylglycerol binding domain (C1 domain)
- RhoGAP domain
- GEM-interacting protein-like, FCH domain
- Rho GTPase-activating protein 29/45 N-terminal
KeywordsUniProt
InteractionsUniProt · HPA
Protein binding partners of ARHGAP29 in the human serome: UniProt-annotated complex subunits plus reported interactors. Each links to its own Seroatlas record.
Antibody and autoantibody relevanceSeroatlas analysis
Seroatlas reads ARHGAP29 as an antibody target. Whether an autoantibody or antibody against ARHGAP29 could matter depends on whether native ARHGAP29 is physically reachable, whether the body needs it intact, and whether it acts in a disease-relevant tissue.
ARHGAP29 is annotated as predominantly intracellular. Intracellular proteins are common autoantibody markers, becoming visible to the immune system after cell injury or altered processing, but are usually markers of disease rather than direct drivers.
Annotation status
The present source text does not explicitly label ARHGAP29 as an autoantigen. Seroatlas presents hypothesis context only and does not manufacture a known-serology claim.
Loading the interactive Seroatlas protein explorer...